HOME › Research Insight › Hemodialysis & Peritoneal Dialysis Market - Global Forecast To 2018
Hemodialysis & Peritoneal Dialysis Market - Global Forecast To 2018
The global dialysis market is dominated by Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Baxter International, Inc. (U.S.), and Gambro AB (Sweden). These four companies accounted for a share of ~45% of the global dialysis market in 2012. Fresenius Medical Care is the leader in the hemodialysis as well as the peritoneal dialysis products and services market and is expected to rule the market in next five years as well. The company has a broad product portfolio which includes products under various categories such as, chronic hemodialysis, home dialysis, renal pharmaceuticals, acute therapy, therapeutic apheresis, therapy support, and water technology. The company treats around 258,000 dialysis patients at its 3,200 dialysis clinics in almost 40 countries. It has a large work force and as of 2013, it employed ~86,153 employees in more than 120 countries. The company’s wide range of product and service offerings coupled with its wide geographic presence enables it to maintain its leading position in the global dialysis market. Furthermore, the company has adopted partnerships, new product launch, and acquisitions as its key business strategies to sustain it position in the market.
DaVita Healthcare Partners, Inc. (U.S.) ranks second in the global dialysis market with a market share of ~14% in 2012 and is expected to a give stiff competition to Fresenius in the next five years. The company is engaged in providing a wide array of renal care services to patients in the U.S. and in other countries across the globe. It offers dialysis services under three operating segments, namely, dialysis and related lab services, HCP (HealthCare Partners), and other ancillary services and strategic initiatives. As of June 2013, DaVita provided renal care services to around 159,000 patients at 2,010 outpatient dialysis centers in the U.S. In order to increase its share in the global dialysis market, the company has been concentrating on acquisitions as its key business strategy.
Partnerships, agreements, collaborations, joint ventures, and acquisitions are the key growth strategies adopted by leading industry participants. Market players adopted these strategies to access new technologies, expand their products and services portfolio, enter into growing markets, and/or increase their market share. In addition to the top market players, companies such as Nikkiso Co. Ltd. (Japan), Diaverum Deutschland GmbH (Germany), and Nipro Corporation (Japan) primarily focused on acquisitions to widen their product offerings. Companies such as B. Braun Melsungen AG (Germany), Kawasumi Laboratories, Inc. (Japan), and Covidien (Ireland) adopted the strategy of expansion to sustain their growth in the dialysis market.
Major strategic developments are taking place in the field of dialysis consumables and accessories, and the home dialysis market, which exhibits high-growth potential in the near future. Dominant market players such as Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc. (U.S.), and Gambro AB (Sweden) introduced several dialysis consumables, accessories, and home dialysis equipment in order to keep pace with the industry trends. In addition, evolution of new treatment techniques (PD Plus therapy and home hemodialysis) also represents new growth opportunities for companies in the global dialysis market.
Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018.